Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 25


Trimodality therapy in bladder cancer: who, what, and when?

Premo C, Apolo AB, Agarwal PK, Citrin DE.

Urol Clin North Am. 2015 May;42(2):169-80, vii. doi: 10.1016/j.ucl.2015.02.002. Review.


Long-term outcomes in patients with muscle-invasive bladder cancer after selective bladder-preserving combined-modality therapy: a pooled analysis of Radiation Therapy Oncology Group protocols 8802, 8903, 9506, 9706, 9906, and 0233.

Mak RH, Hunt D, Shipley WU, Efstathiou JA, Tester WJ, Hagan MP, Kaufman DS, Heney NM, Zietman AL.

J Clin Oncol. 2014 Dec 1;32(34):3801-9. doi: 10.1200/JCO.2014.57.5548. Epub 2014 Nov 3. Erratum in: J Clin Oncol. 2015 Mar 1;33(7):814.


Trimodality bladder-sparing approach without neoadjuvant chemotherapy for node-negative localized muscle-invasive urinary bladder cancer resulted in comparable cystectomy-free survival.

Lee CY, Yang KL, Ko HL, Huang RY, Tsai PP, Chen MT, Lin YC, Hwang TI, Juang GD, Chi KH.

Radiat Oncol. 2014 Sep 24;9:213. doi: 10.1186/1748-717X-9-213.


Trimodality therapy for bladder preservation in the elderly population with invasive bladder cancer.

Turgeon GA, Souhami L.

Front Oncol. 2014 Aug 5;4:206. doi: 10.3389/fonc.2014.00206. eCollection 2014. Review.


Multimodal management of muscle-invasive bladder cancer.

Park JC, Citrin DE, Agarwal PK, Apolo AB.

Curr Probl Cancer. 2014 May-Jun;38(3):80-108. doi: 10.1016/j.currproblcancer.2014.06.001. Epub 2014 Jun 23. Review. No abstract available.


New therapeutic targets in the management of urothelial carcinoma of the bladder.

Sverrisson EF, Espiritu PN, Spiess PE.

Res Rep Urol. 2013 Mar 1;5:53-65. doi: 10.2147/RRU.S29131.


Radio-chemotherapy for bladder cancer: Contribution of chemotherapy on local control.

Plataniotis GA, Dale RG.

World J Radiol. 2013 Aug 28;5(8):267-74. doi: 10.4329/wjr.v5.i8.267. Review.


Bladder preservation for localized muscle-invasive bladder cancer: the survival impact of local utilization rates of definitive radiotherapy.

Kozak KR, Hamidi M, Manning M, Moody JS.

Int J Radiat Oncol Biol Phys. 2012 Jun 1;83(2):e197-204. doi: 10.1016/j.ijrobp.2011.12.038. Epub 2012 Mar 6.


Multimodal therapies for muscle-invasive urothelial carcinoma of the bladder.

Keegan KA, Resnick MJ, Clark PE.

Curr Opin Oncol. 2012 May;24(3):278-83. doi: 10.1097/CCO.0b013e3283510587. Review.


Update on chemotherapy in the treatment of urothelial carcinoma.

Costantini C, Millard F.

ScientificWorldJournal. 2011;11:1981-94. doi: 10.1100/2011/590175. Epub 2011 Oct 26. Review.


Management of invasive bladder cancer in patients who are not candidates for or decline cystectomy.

Balar A, Bajorin DF, Milowsky MI.

Ther Adv Urol. 2011 Jun;3(3):107-17. doi: 10.1177/1756287211407543.


Role of systemic peri-operative chemotherapy in management of transitional cell carcinoma of bladder.

Nayyar R, Gupta NP.

Indian J Urol. 2011 Apr;27(2):262-8. doi: 10.4103/0970-1591.82847.


Current therapeutic strategies for invasive and metastatic bladder cancer.

Vishnu P, Mathew J, Tan WW.

Onco Targets Ther. 2011;4:97-113. doi: 10.2147/OTT.S22875. Epub 2011 Jul 11.


In favour of bladder preservation using combined modality treatment.

Lukka H.

Can Urol Assoc J. 2009 Oct;3(5):412-5. No abstract available.


Conservative treatment of invasive bladder cancer.

Rene NJ, Cury FB, Souhami L.

Curr Oncol. 2009 Aug;16(4):36-47.


Late pelvic toxicity after bladder-sparing therapy in patients with invasive bladder cancer: RTOG 89-03, 95-06, 97-06, 99-06.

Efstathiou JA, Bae K, Shipley WU, Kaufman DS, Hagan MP, Heney NM, Sandler HM.

J Clin Oncol. 2009 Sep 1;27(25):4055-61. doi: 10.1200/JCO.2008.19.5776. Epub 2009 Jul 27.


Performing nondiagnostic research biopsies in irradiated tissue: a review of scientific, clinical, and ethical considerations.

Brown AP, Wendler DS, Camphausen KA, Miller FG, Citrin D.

J Clin Oncol. 2008 Aug 20;26(24):3987-94. doi: 10.1200/JCO.2008.16.9896.


Single nucleotide polymorphisms in DNA repair genes might be prognostic factors in muscle-invasive bladder cancer patients treated with chemoradiotherapy.

Sakano S, Wada T, Matsumoto H, Sugiyama S, Inoue R, Eguchi S, Ito H, Ohmi C, Matsuyama H, Naito K.

Br J Cancer. 2006 Sep 4;95(5):561-70. Epub 2006 Aug 1.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk